One way to address the Kovid vaccine shortage and speed up vaccinations is to open up the market for jobs, where private producers can enter to sell the shot to anyone, even as our government-run immunization drive continues. India has just done that. Domestic vaccine manufacturers are required to supply half of their product, while the rest are free to sell to state governments and private buyers, the center said Monday. Imported jobs for clearance can also be sold privately.
It was a good decision. It is unclear how the price of such market doses will be. Under normal circumstances, competition for customers controls prices, but due to our job shortage amid the growing infection curve, it starts as a sellers market, so we can not rely on hostility to do that work. Imposing a price limit is best for the center. However, this should not be underestimated, as entrants will be blocked. Also, they need good margins if local producers are to make profits and use their earnings to give cross-subsidy to supply cheap to the center. Moreover, costs vary; mRNA jobs, for example, require expensive storage facilities. All are considered, its upper limit ₹Tell Jabra 1,000, can work. Hopefully, the actual prices we face will be lower.